12 reports

Psoriatic arthritis

4546 5000 3864
  • FRANCE PSORIATIC ARTHRITIS TREATMENT RATE AND USAGE OF BIOLOGIC THERAPIES, BY DISEASE SEVERITY AND LINE OF THERAPY
  • GERMANY PSORIATIC ARTHRITIS TREATMENT RATE AND USAGE OF BIOLOGIC THERAPIES, BY DISEASE SEVERITY AND LINE OF THERAPY
  • Biological Therapy
  • Europe
  • Amgen Inc.
  • Celgene Corporation
  • Johnson & Johnson

THE TREATMENT THROUGH BIOLOGICS IS GENERALLY VERY EXPENSIVE.

  • Biological Therapy
  • Biopharmaceutical
  • Biosimilar
  • Pharmaceutical
  • Europe
  • BRISTOL-MYERS SQUIBB (U.S.)

ENDOTOXIN TESTING IS USED IN CELL THERAPY, MONOCLONAL ANTIBODY TESTING, VACCINE TESTING, GENE THERAPY, AND DRUG DEVELOPMENT.

  • Biological Therapy
  • Europe
  • North America
  • World
  • Merck & Co., Inc.

There are two phases: Allergy Shots ##. ## Allergy Immunotherapy: An Overview Immunotherapy or biologic therapy, is a therapy that is designed to boost the body" s natural defenses to fight the disease/ allergy.

  • Allergy Immunotherapy
  • Biological Therapy
  • Europe
  • Market Size
  • Allergy Therapeutics plc

XBiotech' s True Human antibody, MABp##, is expected to have the smallest immunogenic footprint possible for a biological drug.

  • Biological Therapy
  • Therapy
  • Europe
  • Product Initiative
  • XBiotech Inc.

(XBiotech) is a bio-pharmaceutical company that develops biological therapies and treatments.

  • Biological Therapy
  • Therapy
  • Europe
  • Product Initiative
  • XBiotech Inc.

Orphan drug designations are granted to drugs or biologics that are being investigated for the treatment of a rare disease or condition.

  • Biological Therapy
  • Pharmaceutical
  • Therapy
  • Europe
  • TiGenix NV

The molecule also exhibited an excellent safety and tolerability profile with very low rates of infection (~##%) in active treatment arms suggesting a favorable risk benefit profile compared to currently available biologic treatments.

  • Biological Therapy
  • Monoclonal Antibody
  • Neurological Disorder
  • Therapy
  • Europe

RESULTS DEMONSTRATED THAT ANEUSTAT WAS WELL TOLERATED AT ALL DOSES TESTED AND HAD DOSE-RESPONSIVE BIOLOGICAL ACTIVITY IN PATIENTS WITH ADVANCED TREATMENT REFRACTORY CANCER.

  • Biological Therapy
  • Monoclonal Antibody
  • Therapy
  • Europe
  • XBiotech Inc.

CardioVascular BioTherapeutics reported Phase IIa and Phase IIb clinical trial data for its biological therapy to treat diabetic wounds, CVBT-##B.

  • Biological Therapy
  • Biotech
  • Therapy
  • Type 2 Diabetes
  • Europe

EXPERT OPINION ON BIOLOGICAL THERAPY, ##(##), ##-## < DOI> ##. ##/ ##. ##. ##. ##< / DOI>.

  • Biological Therapy
  • Gene Therapy
  • Europe
  • Product Initiative
  • uniQure N.V.

HEAT BIOLOGICS ##.

  • Biological Therapy
  • Biotechnology
  • Gene Therapy
  • Therapy
  • Europe